#kidneycancer

OncoAlert's profile picture

Day 1 of #ASCO26 delivered practice-changing data across #LungCancer #BladderCancer #KidneyCancer Captured by the OncoAlert 🚨 Round Up 🔹 7-year CROWN update confirms unprecedented durability with lorlatinib in ALK+ NSCLC Tony Mok 🔹 ADC + immunotherapy combination shows major frontline promise in NSCLC 🔹 Sunvozertinib emerges as a new first-line standard for EGFR exon20ins disease 🔹 EV-302 continues to redefine survival in metastatic urothelial carcinoma Tom Powles 🔹 ctDNA analyses from KEYNOTE-564 move us closer to precision adjuvant RCC care Toni Choueiri, MD Catch all the key studies and clinical insights in the latest OncoAlert ASCO 2026 Day 1 Roundup. 🎧 Listen now and stay ahead of the science. #ASCO26 Stephen V Liu, MD Yüksel Ürün Uğur Özkerim Oncology Brothers Sakditad “Tew” Saowapa, MD Dr Rishabh Jain Masahiro TORASAWA, MD. PhD. Ahmed Alanazi | أحمد العنزي David Heredia. Allison Chang Rami Manochakian MD, FASCO Cancer Education 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Rohit Singh, MD Diego A. Díaz-García Tuğba Başoğlu, MD Oriol Mirallas MD Johan Pluvy | Thoracic Oncology News gilberto lopes José Márcio Barros de Figueiredo MD, MSc Hidehito HORINOUCHI Jordi Remon Manuel Dómine, MD, PhD Dr Amol Akhade ilyas sahin, MD Tom Powles Toni Choueiri, MD Dra. María Natalia Gandur Quiroga Shilpa Gupta Emre Yekedüz Shreyas Kalantri, MD Elisabetta Bonzano MD, PhD Zach Klaassen Mario Balsa Wassim Daoud Khatoun Katy Beckermann Andres Meraz-Brenez Fuat Bicer MD, PhD Arpita Desai Javier Puente

OncoAlert

10,985 просмотров • 2 месяцев назад

Больше нет контента для загрузки